This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Robert E. Keith, PhD, RD
Auburn University Auburn, Ala

JAMA. 1986;255(9):1137.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Use of supplements by athletes as a possible means of increasing performance is common. Anabolic steroid administration and blood doping are just two such supplements. Carnitine use among aerobic athletes has been occasionally reported, although it is hard to document. L-Carnitine is the biologically active isomer and could theoretically be of value for endurance. However, because of high cost, the L form would be less likely to be used by athletes than the DL form, which can be obtained inexpensively. Several reports'^1-4 suggest that D-carnitine may inhibit the action of the L-isomer, thus possibly creating a carnitine-deficiency state. Deficiency of an enzyme that uses carnitine, carnitine palmityl transferase, has been described in humans⁵ and produces symptoms of muscle cramps, myoglobinuria, and muscle weakness. Symptoms become progressively worse during prolonged exercise, after consumption of high-fat diets, with fasting, or during cold weather.

Report of a Case.— . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?